Home » Barclays Annual Reports » 2004 Annual Report - page 41

Barclays 2004 Annual Report Download - page 41

Download and view the complete annual report

Please find page 41 of the 2004 Barclays annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Barclays PLC Annual Report 2004

Directors: interests in ordinary shares of Barclays PLC(a)

At 1st January 2004(b) At 31st December 2004

Non- Non-

Beneficial beneficial Beneficial beneficial

Chairman

MW Barrett 277,656 – 289,242 –

Executive Directors

JS Varley(c) 303,735 – 338,451 –

RJ Davis 3,156 – 3,156 –

GA Hoffman(c) 126,444 – 168,240 –

N Kheraj 2,238 – 2,238 –

CJ Lendrum(d) 224,456 – 239,373 –

DL Roberts(c) 62,034 – 67,368 –

Non-executive Directors(e)

TDG Arculus 14,289 – 17,428 –

Sir Richard Broadbent 2,000 – 3,992 –

RL Clifford(f) ––2,000 –

Professor Dame Sandra Dawson 2,808 – 5,460 –

Sir Andrew Likierman(g) ––2,000 –

Sir Nigel Rudd 11,427 – 14,367 –

SG Russell 10,609 – 13,774 –

Dr Jürgen Zech 5,195 – 7,964 –

Notes

(a) Beneficial interests in the table above represent shares held by Directors who were on the Board as at 31st December 2004, either directly or through a nominee,

their spouse or children under 18. They include any interests held through the 1991 UK Profit Sharing Schemes (PSS) and Sharepurchase, but do not include any

awards under ESAS, ISOP, PSP, ESOS and Sharesave schemes. At 31st December 2004, Matthew W Barrett and the executive Directors, together with other senior

executives, were potential beneficiaries in respect of a total of 115,956,111 Barclays PLC ordinary shares (1st January 2004: 82,797,943) held by the trustees of

the Barclays Group Employees’ Benefit Trusts. At 28th February 2005, a total of 148,391,046 shares were held by the trustees.

(b) Or date appointed to the Board if later.

(c) Between 31st December 2004 and 28th February 2005, 42 ordinary shares were purchased for each of John Varley, Gary Hoffman and David Robertsthrough

Sharepurchase.

(d) Chris Lendrum ceased to be a Director on 31st December 2004.

(e) On 10th February 2005 the following non-executive Directors received the amounts of shares set out after their names in respect of part of their Board and

(where applicable) Board Committee fees: David Arculus: 1,138; Sir Richard Broadbent: 972; Leigh Clifford: 580; Professor Dame Sandra Dawson: 1,206;

Sir Andrew Likierman: 717; Sir Nigel Rudd: 1,137; Stephen Russell: 1,115; Dr Jürgen Zech: 1,085.

(f) Appointed with effect from 1st October 2004.

(g) Appointed with effect from 1st September 2004.